Predicting Tumour Progression of ID-8 Syngeneic Mouse Ovarian Cancer with Blood Biomarkers of CA-125, IL-6 and VEGF: A Prospective Laboratory-Based Study
Background: A preclinical animal model is an imperative tool for uncovering and understanding the tumourigenic hallmarks of human ovarian cancer; the disease is often lethal because it is commonly diagnosed in the advanced stage, where widespread cancer nodules mainly reside within peritoneal region...
Main Authors: | Kenny Chitcholtan, Arron Dyer, Peter Sykes |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2023-10-01
|
Series: | Clinical and Experimental Obstetrics & Gynecology |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/CEOG/50/10/10.31083/j.ceog5010212 |
Similar Items
-
CA-125 and Ceruloplasmin Levels in Ovarian Cancer Patients
by: Mangala Hegde, et al.
Published: (2015-09-01) -
CA125 and Ovarian Cancer: A Comprehensive Review
by: Parsa Charkhchi, et al.
Published: (2020-12-01) -
Factors associated with serum CA125 level in women without ovarian cancer in the United States: a population-based study
by: Xiao Hu, et al.
Published: (2022-05-01) -
Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125
by: Szu-Ting Yang, et al.
Published: (2023-11-01) -
Ovarian Cavernous Hemangioma Presenting as an Left Adnexal Mass with Elevated Ca-125: A Case Report
by: Nilüfer Onak Kandemir, et al.
Published: (2008-04-01)